Mayo Medical Laboratories and Mayo Clinic’s Laboratory Medicine and Pathology Graduate Medical Education Office have developed Mayo Clinic PathWays, an online learning tool for pathologists and for those who enjoy learning about medicine. Practical case studies will be posted weekly to the Mayo Medical Laboratories blog for medical professionals around the world.
Mayo Medical Laboratories is partnering with Seattle Children’s Hospital to research and develop ways to help the children’s hospitals around the country decrease costs and potential errors associated with unnecessary laboratory testing.
US Senator Amy Klobuchar will tour the Mayo Clinic Biobank and discuss the Precision Medicine Initiative with leadership from both the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories on Friday, Feb. 20 from 11:15 to 11:40 a.m.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a new genomic test that can direct appropriate use of radiation therapy following prostate surgery.
Leica Biosystems and Mayo Clinic’s Department of Laboratory Medicine and Pathology announced today a collaboration to develop the next generation of cytogenetics imaging software.
According to a recent Mayo Clinic-led study, most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.
A Mayo Clinic study has found a diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
Hunterdon Healthcare has selected Mayo Medical Laboratories, which will give them access to our extensive menu of laboratory tests and clinical expertise.
GenomeDx Biosciences today announced that the company has expanded its research agreement with Mayo Clinic to initiate a validation study to expand the use of the Decipher® Prostate Cancer Classifier, a genomic test capable of predicting metastatic prostate cancer, for use in prostate biopsy specimens.
The International Myeloma Working Group (IMWG) announced that it has updated the criteria for diagnosing multiple myeloma. Mayo Clinic hematologist, S. Vincent Rajkumar, M.D., is the lead author on a paper, which outlines the new criteria.
Shore Medical Center (SMC) has selected Mayo Medical Laboratories as its primary reference laboratory. Based in Somers Point, N.J., Shore Medical Center will continue to conduct most of its own inpatient and outpatient testing, but will leverage its collaboration with Mayo Medical Laboratories to access to more advanced diagnostic and newly developed tests.
Advanced Biological Laboratories, S.A, and Mayo Medical Laboratories have announced a collaboration agreement to develop a deep-sequencing pipeline for novel diagnostic laboratory-developed tests.
Due to the Labor Day holiday, observed Monday, Sept. 1 in the United States, Mayo Medical Laboratories’ specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turn-around time are not affected, plan ahead and note that no pickups or deliveries will be made on Sept. 1 by our couriers or FedEx.